Blood Pressure Drug Pulled From Shelves After Carcinogen Detected

Learn about the recent blood pressure drug recalled by Teva Pharmaceuticals due to a harmful chemical impurity.

Hearing that a medication you take every day might not be safe anymore can really make your stomach drop. That is what happened when a blood pressure drug recalled by Teva Pharmaceuticals hit the news. The company found a chemical impurity in several batches of prazosin hydrochloride, something that could increase cancer risk over time.

People all over the country started asking the same thing, what now? The recall does not mean the medicine was instantly dangerous, but it does raise questions about how something like this happens.

What Happened and Why It Matters

Early in October 2025, Teva Pharmaceuticals, a big name in generic drugs, voluntarily pulled hundreds of thousands of bottles of prazosin hydrochloride from pharmacy shelves. The blood pressure medication recalled covered 1 mg, 2 mg, and 5 mg strengths.

Tests found an impurity called N-nitroso prazosin, which belongs to a group of chemicals known as nitrosamines. These are not new villains; scientists have been watching them for years because they can form during drug production and might cause cancer after long exposure.

The Food and Drug Administration later listed it as a Class II recall, which means the chance of serious harm is small. Still, no one wants a cancer-causing chemical in their daily pills. The news was unsettling for patients who depend on the drug to keep their blood pressure steady.